SCHEMBL4664485

SCHEMBL4664485

C[C@@H](NC(=O)c1ccncc1)C(N)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.54
MAOB P27338 1/20 0.54
PTGS2 P35354 1/20 0.54
KDM4E B2RXH2 1/20 0.53
MPO P05164 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2A6 P11509 1/20 0.53
CYP2C19 P33261 1/20 0.53
ALDH1A1 P00352 2/20 0.52
CA1 P00915 2/20 0.50
CA9 Q16790 2/20 0.50
HPGD P15428 2/20 0.50
LMNA P02545 2/20 0.50
CA12 O43570 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
TP53 P04637 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12320662 1.00 MAOA (0.54) MAOAMAOBPTGS2KDM4EMPO
SCHEMBL8803477 1.00 MAOA (0.54) MAOAMAOBPTGS2KDM4EMPO
SCHEMBL18457430 0.84 MAOA (0.56) MAOAMAOBPTGS2KDM4EMPO
SCHEMBL2917517 0.84 CA2 (0.57) MAOAMAOBPTGS2KDM4EMPO
SCHEMBL5131090 0.84 CA2 (0.57) MAOAMAOBPTGS2KDM4EMPO
SCHEMBL24590569 0.84 MAOA (0.56) MAOAMAOBPTGS2KDM4EMPO
SCHEMBL2917519 0.84 CA2 (0.57) MAOAMAOBPTGS2KDM4EMPO
SCHEMBL3363035 0.83 MAOA (0.70) MAOAMAOBPTGS2KDM4EMPO
SCHEMBL18970073 0.83 HPGDS (0.55) MAOAMAOBPTGS2KDM4EMPO
SCHEMBL10064613 0.83 HPGDS (0.55) MAOAMAOBPTGS2KDM4EMPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1395551-B1 HYDROXY ALKYL AMINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND THEIR USE FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND SIMILAR DISEASES ELAN PHARM INC (US) 2008-05-21 EP claimed
EP-1395551-A2 HYDROXY ALKYL AMINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND THEIR USE FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND SIMILAR DISEASES Elan Pharmaceuticals, Inc. (US) 2004-03-10 EP claimed
WO-2002098849-A2 HYDROXY ALKYL AMINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND THEIR USE FOR THE TREATMENT OF ALZHEIMER’S DISEASE AND SIMILAR DISEASES ELAN PHARMACEUTICALS, INC. (US) 2002-12-12 WO claimed
EP-1395551-A2 HYDROXY ALKYL AMINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND THEIR USE FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND SIMILAR DISEASES Elan Pharmaceuticals, Inc. (US) 2004-03-10 EP disclosed
WO-2002098849-A2 HYDROXY ALKYL AMINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND THEIR USE FOR THE TREATMENT OF ALZHEIMER’S DISEASE AND SIMILAR DISEASES ELAN PHARMACEUTICALS, INC. (US) 2002-12-12 WO disclosed